[10 years of testing of the HER2 status in breast cancer in Russia]

G A Frank; Iu Iu Andreeva; I Iu Vinogradov; S B Glatko; M Z Gorelik; L E Zavalishina; E E Leenman; A E Matsionis; S V Petrov; S V Sazonov

[10 years of testing of the HER2 status in breast cancer in Russia]

Arkh Patol. 2012 Sep-Oct;74(5):3-6.

[Article in Russian]

Authors

G A Frank, Iu Iu Andreeva, I Iu Vinogradov, S B Glatko, M Z Gorelik, L E Zavalishina, E E Leenman, A E Matsionis, S V Petrov, S V Sazonov

PMID: 23342651

Abstract

The paper analyzes 10 years' experience in HER2 status testing in breast cancer in Russia. The ASCO/CAP HER2 testing guidelines adaptable to the work of pathologists in Russia are considered.

Publication types

Editorial
English Abstract

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Breast Neoplasms* / drug therapy
Breast Neoplasms* / epidemiology
Breast Neoplasms* / metabolism
Female
Humans
Immunohistochemistry / instrumentation
Immunohistochemistry / methods
Neoplasms, Hormone-Dependent / drug therapy
Neoplasms, Hormone-Dependent / metabolism
Receptor, ErbB-2* / genetics
Receptor, ErbB-2* / metabolism
Reference Standards
Russia / epidemiology
Trastuzumab

Substances

Antibodies, Monoclonal, Humanized
ERBB2 protein, human
Receptor, ErbB-2
Trastuzumab